These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1346838)

  • 21. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
    Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ondansetron and cisplatin-induced nausea and vomiting.
    Hait WN
    N Engl J Med; 1990 Nov; 323(21):1485-6. PubMed ID: 2146502
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.
    Nakagaki M; Barras M; Curley C; Butler JP; Kennedy GA
    Support Care Cancer; 2017 Feb; 25(2):607-613. PubMed ID: 27738796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ondansetron is effective in decreasing postoperative nausea and vomiting.
    Dershwitz M; Rosow CE; Di Biase PM; Joslyn AF; Sanderson PE
    Clin Pharmacol Ther; 1992 Jul; 52(1):96-101. PubMed ID: 1385567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of ondansetron for undifferentiated nausea and vomiting in the prehospital setting.
    Warden CR; Moreno R; Daya M
    Prehosp Emerg Care; 2008; 12(1):87-91. PubMed ID: 18189184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
    Herrstedt J; Ersbøll J; Dombernowsky P
    Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes.
    Schmoll HJ
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S35-9. PubMed ID: 2533897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ondansetron compared with metoclopramide in the treatment of PONV.
    Harper CM; Barker JP
    Br J Anaesth; 1998 Mar; 80(3):407-8. PubMed ID: 9623448
    [No Abstract]   [Full Text] [Related]  

  • 35. Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens.
    Cubeddu LX; Hoffman IS; Fuenmayor NT; Finn AL
    J Clin Oncol; 1990 Oct; 8(10):1721-7. PubMed ID: 2145400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ondansetron compared with metoclopramide in the treatment of established postoperative nausea and vomiting. The French Ondansetron Study Group.
    Diemunsch P; Conseiller C; Clyti N; Mamet JP
    Br J Anaesth; 1997 Sep; 79(3):322-6. PubMed ID: 9389849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ondansetron in the prophylaxis of acute cisplatin-induced nausea and vomiting.
    Marty M
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S41-5. PubMed ID: 2533898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An audit of the use of ondansetron in general medical patients.
    Cotton PJ; Noaman SQ
    Med J Aust; 2013 Dec; 199(11):748-50. PubMed ID: 24329638
    [No Abstract]   [Full Text] [Related]  

  • 39. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 40. Ondansetron for patients given abdominal radiotherapy.
    Rosenthal SA; Marquez CM; Hourigan HP; Ryu JK
    Lancet; 1992 Feb; 339(8791):490. PubMed ID: 1346837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.